A pilot trial of 5-FU, leucovorin, and cisplatin with or without adriamycin in advanced cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 3, 1996, Pages 241-244

  Vaughn, David J ^a   Meropol, Neal J ^b   Armstead, Barbara ^a   Haller, Daniel G ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

5 FU; Adriamycin; Cisplatin; Leucovorin; Upper gastrointestinal cancer chemotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DIGESTIVE SYSTEM CANCER; FEMALE; GASTROINTESTINAL CARCINOMA; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; THROMBOCYTOPENIA; TUMOR BIOPSY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS;

EID: 0029894540     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199606000-00006     Document Type: Article

References (12)

1. Havlin KA, Macdonald JS. Gastric cancer: chemotherapy of advanced disease. In: Ahlgren JD, Macdonald JS, eds. Gastrointestinal oncology. Philadelphia: JB Lippincott, 1992:171-80.
2. Reed E. Platinum analogues. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: the principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993:390-400.
3. Chabner BA, Myers CE. Antitumor antibiotics. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: the principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993:374-84.
4. Moertel CG, Rubin J, O'Connell MJ, et al. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced gastrointestinal adenocarcinoma. J Clin Oncol 1986;4:1053-7.
5. Haller DG. Chemotherapy in gastrointestinal malignancies. Semin Oncol 1988;15:50-64.
6. Schant SP, Harrison LB, Hong WK. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. Cancer of the head and neck. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: the principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993:574-630.
7. Einhorn LH. Improvements in fluorouracil chemotherapy? J Clin Oncol 1989;10:1377-9.
8. Poon MA, O'Connell MJ, Moertel CG, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal cancer. J Clin Oncol 1989;7:890-9.
9. Erlichman C, Fine S, Wong A, et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988;6:469-75.
10. The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colon cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
11. Arbuck SG, Douglass HO Jr, Trave F, et al. A phase II study of 5-fluorouracil and high dose folinic acid in gastric carcinoma. J Clin Oncol 1987;5:115-22.
12. Madajewicz S, Petrelli N, Rustrum YM, et al. Phase I-II trial of high dose calcium leucovorin and 5-fluorouracil in advanced colorectal carcinoma. Cancer Res 1984;44:4667-9.